Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Share News

34567891011

Hutchmed receives USD15 million from AstraZeneca for Saffron progress

7th Mar 2022 10:04

(Alliance News) - Hutchmed (China) Ltd on Monday said it has received USD15 million from AstraZeneca PLC as start-up activities for Saffron commenced. Read More

EARNINGS REPORTS: Elementis swings to profit; Hutchmed changes CEO

3rd Mar 2022 13:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Hutchmed in Macau boost; UP Global success in Germany

1st Mar 2022 20:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

24th Feb 2022 15:54

Read More

Hutchmed starts new phase of probe on HMPL-453 as combination therapy

4th Feb 2022 10:36

Hutchmed starts new phase of probe on HMPL-453 as combination therapy Read More

Hutchmed begins phase one study for potential tumour treatment

20th Jan 2022 11:03

Hutchmed begins phase one study for potential tumour treatment Read More

TOP NEWS: Retailer ASOS now to be seen on London Main Market

13th Jan 2022 09:10

TOP NEWS: Retailer ASOS now to be seen on London Main Market Read More

Hutchmed gains breakthrough therapy designation in China for HMPL-523

12th Jan 2022 11:37

Hutchmed gains breakthrough therapy designation in China for HMPL-523 Read More

Hutchmed begins phase one study for potential cancer treatment

10th Jan 2022 09:23

Hutchmed begins phase one study for potential cancer treatment Read More

Hutchmed completes patient enrolment for cancer drug study

6th Dec 2021 10:44

Hutchmed completes patient enrolment for cancer drug study Read More

Two Hutchmed drugs included on China's state approved medicines list

3rd Dec 2021 09:54

Two Hutchmed drugs included on China's state approved medicines list Read More

Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study

24th Nov 2021 11:35

Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study Read More

TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal

1st Nov 2021 09:14

TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal Read More

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

28th Oct 2021 21:59

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug Read More

Hutchmed China sells joint venture stake for USD169 million

29th Sep 2021 11:08

Hutchmed China sells joint venture stake for USD169 million Read More

Hutchmed starts drug combination trial for neuroendocrine tumours

21st Sep 2021 10:51

Hutchmed starts drug combination trial for neuroendocrine tumours Read More

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

20th Sep 2021 09:09

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors Read More

Hutchmed China's amdizalisib secures breakthrough therapy designation

13th Sep 2021 10:22

Hutchmed China's amdizalisib secures breakthrough therapy designation Read More

Hutchmed, Astra launch drug combination trial to treat lung cancer

8th Sep 2021 13:49

Hutchmed, Astra launch drug combination trial to treat lung cancer Read More

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

6th Sep 2021 09:37

Hutchmed China to trade in Shanghai and Shenzhen through link scheme Read More

34567891011
FTSE 100 Latest
Value10,205.77
Change-21.56